Related Articles
Exosomal miR‑130a‑3p promotes the progression of differentiated thyroid cancer by targeting insulin‑like growth factor 1 Retraction in /10.3892/ol.2023.14017
Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis
IGF2 is a potential factor in RAI‑refractory differentiated thyroid cancer
Usefulness of PET/CT in the diagnosis of recurrent or metastasized differentiated thyroid carcinoma
Epithelial‑to‑mesenchymal transition of circulating tumor cells and CD133 expression on predicting prognosis of thyroid cancer patients